Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir.
Bommenel T, Launay O, Meynard JL, Gilquin J, Katlama C, Lascaux AS, Mahamat A, Martinez V, Pradier C, Rouveix E, Simon A, Costagliola D, Abgrall S; FHDH-ANRS CO4. Bommenel T, et al. J Antimicrob Chemother. 2011 Aug;66(8):1869-77. doi: 10.1093/jac/dkr208. Epub 2011 Jun 1. J Antimicrob Chemother. 2011. PMID: 21636583 Clinical Trial.
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.
Parienti JJ, Barrail-Tran A, Duval X, Nembot G, Descamps D, Vigan M, Vrijens B, Panhard X, Taburet AM, Mentré F, Goujard C. Parienti JJ, et al. Among authors: duval x. Antimicrob Agents Chemother. 2013 May;57(5):2265-71. doi: 10.1128/AAC.02605-12. Epub 2013 Mar 4. Antimicrob Agents Chemother. 2013. PMID: 23459496 Free PMC article. Clinical Trial.
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
Burdet C, Grall N, Linard M, Bridier-Nahmias A, Benhayoun M, Bourabha K, Magnan M, Clermont O, d'Humières C, Tenaillon O, Denamur E, Massias L, Tubiana S, Alavoine L, Andremont A, Mentré F, Duval X; CEREMI Group. Burdet C, et al. Among authors: duval x. Antimicrob Agents Chemother. 2019 May 24;63(6):e02244-18. doi: 10.1128/AAC.02244-18. Print 2019 Jun. Antimicrob Agents Chemother. 2019. PMID: 30936104 Free PMC article. Clinical Trial.
Impact of Antibiotic Gut Exposure on the Temporal Changes in Microbiome Diversity.
Burdet C, Nguyen TT, Duval X, Ferreira S, Andremont A, Guedj J, Mentré F; DAV132-CL-1002 Study Group. Burdet C, et al. Among authors: duval x. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00820-19. doi: 10.1128/AAC.00820-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31307985 Free PMC article. Clinical Trial.
Antibiotic prophylaxis of infective endocarditis in patients with predisposing cardiac conditions: French cardiologists' implementation of current guidelines.
Cloitre A, Lesclous P, Trochu Q, Selton-Suty C, Boutoille D, Le Tourneau T, Delahaye F, Thomas D, Iung B, Gaudin A, Duval X, Trochu JN. Cloitre A, et al. Among authors: duval x. Int J Cardiol. 2020 Jan 15;299:222-227. doi: 10.1016/j.ijcard.2019.07.042. Epub 2019 Jul 12. Int J Cardiol. 2020. PMID: 31327512
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort.
Tubiana S, Varon E, Biron C, Ploy MC, Mourvillier B, Taha MK, Revest M, Poyart C, Martin-Blondel G, Lecuit M, Cua E, Pasquet B, Preau M, Hoen B, Duval X; COMBAT study group. Tubiana S, et al. Among authors: duval x. Clin Microbiol Infect. 2020 Sep;26(9):1192-1200. doi: 10.1016/j.cmi.2019.12.020. Epub 2020 Jan 10. Clin Microbiol Infect. 2020. PMID: 31927117 Free article.
451 results